BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24156935)

  • 1. Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes.
    Morote J; Celma A; Planas J; Placer J; Konstantinidis C; Iztueta I; de Torres IM; Oliván M; Reventós J; Doll A
    Actas Urol Esp; 2014 May; 38(4):232-7. PubMed ID: 24156935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome increases the risk of aggressive prostate cancer detection.
    Morote J; Ropero J; Planas J; Bastarós JM; Delgado G; Placer J; Celma A; de Torres IM; Carles J; Reventós J; Doll A
    BJU Int; 2013 Jun; 111(7):1031-6. PubMed ID: 22883053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
    Freedland SJ; Terris MK; Platz EA; Presti JC
    Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
    De Nunzio C; Albisinni S; Freedland SJ; Miano L; Cindolo L; Finazzi Agrò E; Autorino R; De Sio M; Schips L; Tubaro A
    Urol Oncol; 2013 Oct; 31(7):997-1002. PubMed ID: 21925906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?
    Chamie K; Oberfoell S; Kwan L; Labo J; Wei JT; Litwin MS
    Urology; 2013 May; 81(5):949-55. PubMed ID: 23477756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
    Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
    BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
    Park J; Cho SY; Lee SB; Son H; Jeong H
    BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.
    De Nunzio C; Freedland SJ; Miano L; Finazzi Agrò E; Bañez L; Tubaro A
    Eur J Surg Oncol; 2011 Dec; 37(12):1025-9. PubMed ID: 21963050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
    Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
    Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
    Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
    Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
    Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.
    Fowler JE; Bigler SA; Miles D; Yalkut DA
    J Urol; 2000 Mar; 163(3):813-8. PubMed ID: 10687983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical impact of body mass index on prostate biopsy in patients with intermediate PSA levels].
    Sekita N; Suzuki H; Kamijima S; Chini K; Fujimura M; Mikami K
    Hinyokika Kiyo; 2008 Jul; 54(7):479-83. PubMed ID: 18697492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.